Page 2 - Data Review Committee News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Napp announces authorisation of REZZAYO® (rezafungin) in Great Britain by the UK Medicines and Healthcare Products Regulatory Agency for the treatment of invasive candidiasis in adults¹

Napp announces authorisation of REZZAYO® (rezafungin) in Great Britain by the UK Medicines and Healthcare Products Regulatory Agency for the treatment of invasive candidiasis in adults¹
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomGreat britainP lewis whiteBen davidAsia pacificAntimicrob chemotherHealthcare products regulatory agencyCardiff university centre for trials researchTrademark of cidara therapeutics incData review committeeMycology reference laboratoryNapp pharmaceuticalsNapp pharmaceuticals limitedMedical mediaPharmaceuticals limited

Mundipharma announces European approval of REZZAYO (rezafungin) for the treatment of Invasive Candidiasis in adults

Mundipharma announces European approval of REZZAYO (rezafungin) for the treatment of Invasive Candidiasis in adults
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesAntimicrob chemotherOliver cornelyStefan klotterAsia pacificYuri martinaCommittee for medicinal products human useEuropean unionCommunity registerUniversity hospital cologneEuropean commissionCidara therapeutics incData review committeeFor tradeMedical mediaMedicinal products

Cidara Therapeutics (CDTX) Announces EU Approval of REZZAYO

Cidara Therapeutics (CDTX) Announces EU Approval of REZZAYO
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesTaylor sandisonOliver cornelyCidara therapeutics incData review committeeCommittee for medicinal products human useEuropean commissionEuropean unionUniversity hospital cologneCidara therapeuticsMedicinal productsHuman useEuropean excellence centreMedical mycologyEuropean commissionmarksChief medical officer

Cidara Therapeutics Announces European Approval of REZZAYO® (rezafungin) for the Treatment of Invasive Candidiasis in Adults

Approval based on positive results from the pivotal ReSTORE Phase III clinical trial and supported by the STRIVE Phase II clinical trials and extensive nonclinical development program.REZZAYO.

San diegoUnited statesOliver cornelyBrian ritchieVeronica eamesTaylor sandisonData review committeeCidara therapeutics incEuropean unionExchange commissionUniversity hospitalSecurities exchangeEuropean medicines agencyEuropean excellence centre for medical mycologyEuropean commissionGlobenewswire inc

Mundipharma announces European approval of REZZAYO® (rezafungin) for the treatment of Invasive Candidiasis in adults

Mundipharma announces European approval of REZZAYO® (rezafungin) for the treatment of Invasive Candidiasis in adults
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesAsia pacificOliver cornelyYuri martinaAntimicrob chemotherCommittee for medicinal products human useData review committeeEuropean unionUniversity hospital cologneEuropean commissionCidara therapeutics incCommunity registerFor tradeMedical mediaMedicinal products